CN104799298A - 一种以虾青素与欧米伽3结合的营养补充液 - Google Patents
一种以虾青素与欧米伽3结合的营养补充液 Download PDFInfo
- Publication number
- CN104799298A CN104799298A CN201510257121.9A CN201510257121A CN104799298A CN 104799298 A CN104799298 A CN 104799298A CN 201510257121 A CN201510257121 A CN 201510257121A CN 104799298 A CN104799298 A CN 104799298A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- oil
- omega
- seed oil
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 65
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 65
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 65
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 65
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 65
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 36
- 239000007788 liquid Substances 0.000 title claims abstract description 32
- 230000035764 nutrition Effects 0.000 title abstract description 8
- 230000001502 supplementing effect Effects 0.000 title abstract 4
- 241000736199 Paeonia Species 0.000 claims abstract description 27
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 27
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 27
- 239000000944 linseed oil Substances 0.000 claims abstract description 27
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims abstract description 27
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 27
- 239000003921 oil Substances 0.000 claims abstract description 26
- 235000019198 oils Nutrition 0.000 claims abstract description 26
- 241000195493 Cryptophyta Species 0.000 claims description 27
- 230000009469 supplementation Effects 0.000 claims description 27
- 239000010495 camellia oil Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 208000017667 Chronic Disease Diseases 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 230000009385 viral infection Effects 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 4
- 241000003595 Aurantiochytrium limacinum Species 0.000 abstract 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000036995 brain health Effects 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229930195730 Aflatoxin Natural products 0.000 description 2
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 241000229722 Perilla <angiosperm> Species 0.000 description 2
- 239000005409 aflatoxin Substances 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010061523 Lip and/or oral cavity cancer Diseases 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 210000002937 blood-testis barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000013066 combination product Substances 0.000 description 1
- 229940127555 combination product Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000020717 oral cavity carcinoma Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种以虾青素与欧米伽3结合的营养补充液。所述营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成。将虾青素和与欧米伽3结合,使其单一的虾青素营养价值更加全面,同时让紫苏籽、亚麻籽、牡丹籽植物为主体的α亚麻酸、列壶藻植物为主体的DHA组合的欧米伽3的功能更宽泛,使之在抑制血压血糖上升,降低血清胆固醇含量,改善血液环境增强细胞生命力的同时,更有效的增强人体免疫功能,促进大脑健康,提高抗病毒感染的能力,阻止癌细胞增殖,迅速修复机体损伤,排除体内毒素,降低血清胆固醇含量,降低慢性疾病发病风险的功效。
Description
技术领域
本发明涉及营养食品技术领域,尤其是一种以虾青素与欧米伽3结合的营养补充液。
背景技术
虾青素作为一种最高效的纯天然抗氧化剂,最主要的功能是清除自由基,提高人体抗衰老能力。天然虾青素能够穿透血脑屏障、血胰腺屏障、血睾丸屏障这三大人类主 要屏障,并且是唯一能穿透血脑屏障的类胡萝卜素,因此是可能作用于 脑细胞和眼球视网膜唯一一种类胡萝卜素。虾青素能显著抑制化学物诱导的初期癌变,对暴露于致癌物质中的上皮细胞具有抗增殖作用和强化免疫功能的作用,如抑制膀胱癌、口腔癌、结肠癌、胃癌和乳腺癌的生长。虾青素还能降低黄曲霉毒素的致癌性,对减少黄曲霉毒素诱导的肝肿瘤细胞的数量和体积效果良好。
目前,国内虾青素使用单一,尚未出现虾青素食品的生产,更没有同欧米伽3结合用于食品的营养补充液。
发明内容
本发明的目的在于提供一种以虾青素与欧米伽3结合的营养补充液,将虾青素和与欧米伽3结合,可以补充人体所需的虾青素和与欧米伽3,使其单一的虾青素营养价值更加全面。
本发明解决其技术问题所采用的技术方案是:一种以虾青素与欧米伽3结合的营养补充液,所述营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素25-35份、紫苏籽油15-25份、亚麻籽油15-25份、列壶藻油7-12份、牡丹籽油15-25份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
作为优选的,所述营养补充液的组份按照质量配比为:油脂状的虾青素30份、紫苏籽油20份、亚麻籽油20份、列壶藻油10份、牡丹籽油20份。
优选的,所述营养补充液的组份还包含有茶籽油,所述茶籽油的组份为30-50份。
优选的,所述营养补充液的组份按照质量配比为:油脂状的虾青素30份、紫苏籽油20份、亚麻籽油20份、列壶藻油10份、牡丹籽油20份、茶籽油43份。
含有欧米伽3的紫苏籽、亚麻籽,是α亚麻酸的重要母本植物,列壶藻是产生DHA物质的重要淡水母体植物。这两类优质的富含有欧米伽3的植物品类再与虾青素有机的结合,理论源于中医君、臣、佐、使的理论基础,也符合中医及营养学的复方原理。
再之,其一,紫苏籽、亚麻籽所含“α亚麻酸”提取物的物理形态是脂溶物质,而雨生红藻提取物“虾青素”的物理形态是脂溶物质,列壶藻提取物“DHA”的物理表现形态也是脂溶物质,它们的最初产成品都溶在脂肪中;其二,这些物质的第二种的物理形态就是粉末,将这植物脂肪液体状态的材料,分别按君、臣、佐、使的理论配伍,各自的作用得以提升,对人类功能性疾病的防治,特别是对慢性病的防治有着不可估量的作用。
本发明的有益效果是:将虾青素和与欧米伽3结合,有效的增强人体免疫功能,抗病毒感染和增殖,抑制癌细胞增殖,迅速修复机体损伤,排除体内毒素,抑制血压血糖上升,降低血清胆固醇含量,解决了人们在以往补充上述营养物质时,要吃上众多片剂保健品的困惑,同时探索了一种在食品科研领域中,虾青素与欧米伽3结合的新方法,完善了虾青素与欧米伽3的有机结合的科学课题,避免了食品的过度加工,保护了天然食品的属性,同时使其单一的虾青素营养价值更加全面。
该品类的复方组合产品,日后将会在多种日常食品、儿童食品、功能食品、保健食品中添加,在弥补科研空白的同时,将一种创新品类产品对人类的健康与生命质量的提高做出贡献。
具体实施方式
为了使本发明所解决的技术问题、技术方案及有益效果更加清楚明白,以下结合实施例,对本发明作进一步的说明。应当理解,此处所描述的实施例仅仅用于解释本发明,并不用于限定本发明。
实施例一
一种以虾青素与欧米伽3结合的营养补充液,营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素30份、紫苏籽油20份、亚麻籽油20份、列壶藻油10份、牡丹籽油20份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
实施例二
一种以虾青素与欧米伽3结合的营养补充液,营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素25份、紫苏籽油15份、亚麻籽油15份、列壶藻油7份、牡丹籽油15份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
实施例三
一种以虾青素与欧米伽3结合的营养补充液,营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素35份、紫苏籽油25份、亚麻籽油25份、列壶藻油12份、牡丹籽油25份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
实施例四
一种以虾青素与欧米伽3结合的营养补充液,营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素30份、紫苏籽油18份、亚麻籽油16份、列壶藻油9份、牡丹籽油22份、茶籽油35份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
实施例五
一种以虾青素与欧米伽3结合的营养补充液,营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素33份、紫苏籽油21份、亚麻籽油18份、列壶藻油11份、牡丹籽油18份、茶籽油45份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、同等替换和改进等,均应落在本发明的保护范围之内。
Claims (4)
1.一种以虾青素与欧米伽3结合的营养补充液,其特征在于:所述营养补充液的组份由油脂状的虾青素、紫苏籽油、亚麻籽油、列壶藻油、牡丹籽油配制而成,各组分按照质量配比为:油脂状的虾青素25-35份、紫苏籽油15-25份、亚麻籽油15-25份、列壶藻油7-12份、牡丹籽油15-25份,其中油脂状的虾青素中虾青素的含量≥10%,紫苏籽油中欧米伽3的含量≥55%,亚麻籽油中欧米伽3的含量≥52%,列壶藻油中DNA的含量≥55%,牡丹籽油中欧米伽3的含量≥38%。
2.根据权利要求1所述的一种以虾青素与欧米伽3结合的营养补充液,其特征在于:所述营养补充液的组份按照质量配比为:油脂状的虾青素30份、紫苏籽油20份、亚麻籽油20份、列壶藻油10份、牡丹籽油20份。
3.根据权利要求1所述的一种以虾青素与欧米伽3结合的营养补充液,其特征在于:所述营养补充液的组份还包含有茶籽油,所述茶籽油的组份为30-50份。
4.根据权利要求3所述的一种以虾青素与欧米伽3结合的营养补充液,其特征在于:所述营养补充液的组份按照质量配比为:油脂状的虾青素30份、紫苏籽油20份、亚麻籽油20份、列壶藻油10份、牡丹籽油20份、茶籽油43份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510257121.9A CN104799298A (zh) | 2015-05-20 | 2015-05-20 | 一种以虾青素与欧米伽3结合的营养补充液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510257121.9A CN104799298A (zh) | 2015-05-20 | 2015-05-20 | 一种以虾青素与欧米伽3结合的营养补充液 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104799298A true CN104799298A (zh) | 2015-07-29 |
Family
ID=53684853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510257121.9A Pending CN104799298A (zh) | 2015-05-20 | 2015-05-20 | 一种以虾青素与欧米伽3结合的营养补充液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104799298A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106136243A (zh) * | 2016-08-26 | 2016-11-23 | 李仁宝 | 一种海藻提取物保健软胶囊 |
CN106214768A (zh) * | 2016-09-06 | 2016-12-14 | 郑州师范学院 | 一种牡丹籽油虾青素复合物及其应用 |
CN109907321A (zh) * | 2019-02-15 | 2019-06-21 | 李树森 | 一种高寒地区深海鱼油软胶囊及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014045127A2 (en) * | 2012-09-19 | 2014-03-27 | Aker Biomarine As | Omega-3 phospholipid supplements for females |
CN103719301A (zh) * | 2013-12-24 | 2014-04-16 | 青岛银色世纪健康产业集团有限公司 | 以虾青素油为主料的健康食品 |
CN103766909A (zh) * | 2012-10-17 | 2014-05-07 | 曾晓飞 | 一种富含欧米伽3复配食品补充剂的新型食品 |
JP2014082993A (ja) * | 2012-10-24 | 2014-05-12 | Uha Mikakuto Co Ltd | ガレート型カテキン含有機能性飲料 |
CN104413169A (zh) * | 2013-10-16 | 2015-03-18 | 曾晓飞 | 一种以茶籽油为主,欧米伽3、6、9脂肪酸均衡的营养强化食品 |
CN104522649A (zh) * | 2014-12-18 | 2015-04-22 | 润科生物工程(福建)有限公司 | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 |
-
2015
- 2015-05-20 CN CN201510257121.9A patent/CN104799298A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014045127A2 (en) * | 2012-09-19 | 2014-03-27 | Aker Biomarine As | Omega-3 phospholipid supplements for females |
CN103766909A (zh) * | 2012-10-17 | 2014-05-07 | 曾晓飞 | 一种富含欧米伽3复配食品补充剂的新型食品 |
JP2014082993A (ja) * | 2012-10-24 | 2014-05-12 | Uha Mikakuto Co Ltd | ガレート型カテキン含有機能性飲料 |
CN104413169A (zh) * | 2013-10-16 | 2015-03-18 | 曾晓飞 | 一种以茶籽油为主,欧米伽3、6、9脂肪酸均衡的营养强化食品 |
CN103719301A (zh) * | 2013-12-24 | 2014-04-16 | 青岛银色世纪健康产业集团有限公司 | 以虾青素油为主料的健康食品 |
CN104522649A (zh) * | 2014-12-18 | 2015-04-22 | 润科生物工程(福建)有限公司 | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106136243A (zh) * | 2016-08-26 | 2016-11-23 | 李仁宝 | 一种海藻提取物保健软胶囊 |
CN106214768A (zh) * | 2016-09-06 | 2016-12-14 | 郑州师范学院 | 一种牡丹籽油虾青素复合物及其应用 |
CN109907321A (zh) * | 2019-02-15 | 2019-06-21 | 李树森 | 一种高寒地区深海鱼油软胶囊及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Buono et al. | Functional ingredients from microalgae | |
Udayan et al. | Nutraceuticals from algae and cyanobacteria | |
CN104856055A (zh) | 一种以虾青素与欧米伽3结合的食品补充剂 | |
Basheer et al. | Microalgae in human health and medicine | |
CN104068238A (zh) | 一种膨化鲫鱼饲料及其制备方法 | |
CN102919384B (zh) | 营养保健葵花籽调和油及其制备方法 | |
CN105394452A (zh) | 一种鳜鱼苗专用饲料 | |
CN102246863A (zh) | 一种适合于孕妇和产妇的植物调和油 | |
CN104351358A (zh) | 一种健脑改善记忆的保健食品 | |
CN103875829A (zh) | 核桃黑豆橄榄油 | |
CN105707292A (zh) | 一种适用于婴幼儿的山茶调和油 | |
CN104799298A (zh) | 一种以虾青素与欧米伽3结合的营养补充液 | |
Islam et al. | Microalgae as a sustainable source of nutraceuticals | |
CN104543037A (zh) | 健脑营养油 | |
CN106213505A (zh) | 一种辣木雨生红球藻压片保健品及其制备方法 | |
CN106509158A (zh) | 一种健康调和油 | |
CN102771582A (zh) | 添加南极磷虾油的食用调和油 | |
CN102090486B (zh) | 一种胡麻营养油茶的生产方法 | |
CN104886264A (zh) | 一种青少年特膳牡丹籽营养调和油 | |
CN105638926A (zh) | 一种保健食用油 | |
CN104886272A (zh) | 一种中老年特膳牡丹籽营养调和油 | |
CN103404875A (zh) | 一种供心血管疾病患者食用的复合海洋特膳食品 | |
CN106174218A (zh) | 一种含有硒元素提取物的魔芋精粉保健品 | |
CN105192445A (zh) | 一种草鱼饲料 | |
CN104273246A (zh) | 花生核桃橄榄油 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150729 |
|
WD01 | Invention patent application deemed withdrawn after publication |